What's changing
Providers, payers, and health systems are being asked to hold cost discipline and rising expectations for access and quality at the same time, while the pharma, biotech, and medtech companies that supply them are under equal pressure to commercialize faster without shortening the development cycles regulators and patients depend on. Very few organizations across this value chain are dealing with only one of those pressures.
We've found the operating model and the pipeline are usually the real constraints, not the strategy. Cost-to-serve, technology adoption, launch readiness, and growth all run into the same bottleneck: a model built for a different set of expectations than the one the organization is now being held to.
